Iovance Biotherapeutics IOVA Balance Sheet (2010-2026)

NASDAQ IOVA
$8.79 +0.09 (+1.03%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Iovance Biotherapeutics Quarterly Balance Sheet

Periods 59 quarters
Latest Jun 2026

Iovance Biotherapeutics reported total assets of $915.53M and total liabilities of $179.49M for the quarter ended Jun 2026, up 0.9% year over year. This balance sheet covers 59 quarters of results from Sep 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Dec2013 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
58.59M78.23M92.36M108.08M118.37M231.73M543.48M230.01M267.72M114.89M134.19M228.68M164.19M115.69M171.67M132.47M158.13M163.08M196.51M110.80M
Short-term InvestmentsInvestments (Current)
517.90M426.18M389.83M316.40M241.81M240.11M82.81M20.90M93.70M164.98M222.01M208.09M188.04M168.71M142.70M133.90M116.94M186.91M
Cash & Current Investments
576.49M504.41M482.19M424.48M360.17M471.85M626.29M250.91M361.42M279.87M356.19M228.68M164.19M323.78M359.71M301.18M300.83M296.98M313.44M297.71M
Receivables - NetNet Receivables
0.03M0.15M0.23M31.60M55.77M69.34M70.94M59.94M66.76M82.45M81.76M102.12M
Receivables - OtherOther Receivables
Receivables
0.03M0.15M0.23M31.60M55.77M69.34M70.94M59.94M66.76M82.45M81.76M102.12M
Raw Materials
5.57M27.74M37.91M
Work In Process
8.59M4.30M5.75M5.91M8.77M12.09M
Finished Goods
1.13M4.89M4.62M6.14M15.01M15.54M
Inventory
9.72M9.20M10.37M17.62M51.52M65.55M49.83M51.71M51.68M58.38M55.59M
Prepaid Assets
6.58M3.55M7.78M7.13M9.71M7.27M11.49M14.23M12.02M17.46M11.49M12.38M15.89M11.55M9.82M11.58M12.93M8.87M
Current Assets
583.03M507.96M489.97M431.59M369.88M479.12M637.78M274.88M382.59M307.85M385.53M457.02M512.65M422.50M429.09M442.69M466.50M464.26M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
88.03M100.94M102.76M101.15M100.75M105.23M109.92M112.55M113.14M114.03M111.79M109.08M111.58M122.47M126.65M131.11M131.39M131.46M
Long-Term Investments
78.25M91.59M27.70M
Intangibles
235.51M223.61M239.26M294.30M313.08M322.48M341.39M335.31M335.16M329.70M330.24M
Goodwill & Intangibles
235.51M223.61M239.26M294.30M313.08M322.48M341.39M335.31M335.16M329.70M330.24M
Long-Term Deferred Tax
Other Non-Current Assets
6.08M6.08M6.08M6.43M6.43M6.43M6.43M66.43M66.43M66.43M6.43M6.36M5.82M10.32M9.27M8.17M8.29M6.43M
Non-Current Assets
245.80M269.38M211.28M179.28M176.04M184.87M186.99M482.42M469.73M472.50M484.30M453.41M454.09M484.94M475.86M470.48M459.16M451.27M
Assets
828.83M777.33M701.25M610.88M545.92M663.98M824.77M757.29M852.32M780.35M869.83M910.43M966.74M907.44M904.95M913.17M925.66M915.53M
Liabilities
Current Liabilities
Accounts Payables
12.18M27.38M20.45M20.01M24.25M26.60M31.57M31.16M19.27M33.12M25.70M27.51M28.49M32.00M31.24M22.16M37.45M26.21M
Notes Payables
1.00M1.00M1.00M1.00M1.00M
Payables
12.18M27.38M20.45M20.01M24.25M26.60M31.57M31.16M19.27M33.12M25.70M27.51M29.49M33.00M32.24M23.16M38.45M26.21M
Accumulated Expenses
45.97M56.77M48.91M37.70M47.82M52.30M43.09M46.62M61.21M69.41M46.44M81.94M84.70M89.08M87.27M111.16M88.07M77.96M
Other Accumulated Expenses
2.36M3.76M2.77M3.56M5.41M3.30M4.29M4.57M4.28M6.59M3.98M
Short term Debt
Current Leases
6.62M5.06M7.71M6.48M7.17M12.59M12.61M10.87M10.47M7.78M11.08M12.90M8.50M7.07M6.28M4.04M2.90M2.67M
Total Current Liabilities
64.77M89.20M77.08M64.19M79.25M91.48M87.27M88.64M90.95M110.31M83.21M122.34M122.69M129.16M125.78M138.36M129.42M106.85M
Non-Current Liabilities
Non-Current Debt
1.00M1.00M1.00M1.00M1.00M1.00M1.00M1.00M1.00M1.00M1.00M1.00M
Non-Current Deffered Revenue
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
20.24M18.34M17.35M33.30M32.31M31.96M34.70M31.66M31.83M30.61M29.31M
Operating Leases
64.73M65.47M71.18M73.00M71.94M71.86M69.61M68.84M68.01M67.08M72.29M44.37M44.22M45.10M45.21M44.40M43.88M43.33M
Other Non-Current Liabilities
Total Non-Current Liabilities
65.73M66.47M72.18M74.00M72.94M72.86M70.61M90.08M87.35M85.43M106.59M77.68M76.18M79.79M76.88M76.23M74.49M72.64M
Total Liabilities
130.50M155.67M149.26M138.19M152.19M164.34M157.89M178.72M178.31M195.74M189.81M-768.54M-773.46M200.02M198.88M208.95M202.66M214.59M203.91M179.49M
Shareholder's Equity
Total Debt
1.00M1.00M1.00M1.00M1.00M1.00M1.00M1.00M1.00M1.00M1.00M1.00M1.00M1.00M1.00M1.00M1.00M
Common Equity
698.33M621.66M551.99M472.69M393.74M499.64M666.88M578.57M674.01M584.61M680.02M768.54M773.46M710.40M767.87M698.49M702.29M698.58M721.75M736.04M
Liabilities and Shareholders Equity
828.83M777.33M701.25M610.88M545.92M663.98M824.77M757.29M852.32M780.35M869.83M910.43M966.74M907.44M904.95M913.17M925.66M915.53M
Retained Earnings
1,771.44M1,794.69M1,818.38M1,838.78M1,858.78M2,068.87M2,342.70M2,360.47M2,579.09M2,594.45M2,805.24M3,095.99M3,262.27M3,289.99M3,389.79M3,457.65M3,563.66M3,624.84M
Preferred Shares
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M